In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]
The findings held whether BPC-157 was given prophylactically (before drinking began) or therapeutically (after liver damage was established)
Whether you choose gentle home remedies, targeted skincare, or professional treatments, be patient
Epithalon (also known as Epitalon or Epithalone) is a bioregulator peptide originally developed by Russian scientist Professor Vladimir Khavinson
Use SPF 30+ daily, reapply every 23 hours outdoors, wear full sleeves, hats, and stay in the shade when possible